NOS3 Antibodies

Santa Cruz Biotechnology features a diverse variety of NOS3 monoclonal antibodies for nitric oxide synthase 3 (NOS3) research. NOS3 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NOS3, also known as endothelial nitric oxide synthase (eNOS), plays a central role in the production of nitric oxide, a key signaling molecule involved in vascular homeostasis and regulation of blood flow. The proper functioning of NOS3 is essential for cardiovascular health, as it influences processes such as vasodilation and platelet aggregation. Dysregulation of NOS3 has been implicated in various cardiovascular diseases, making it a significant target for therapeutic intervention. Research into NOS3 function and regulation continues to advance our understanding of cardiovascular biology and disease mechanisms. Investigating NOS3 expression patterns helps identify potential therapeutic strategies for treating cardiovascular disorders. The role of NOS3 in maintaining vascular health makes it a crucial area of study in cardiovascular research. Santa Cruz Biotechnology monoclonal antibodies for NOS3 support researchers worldwide in advancing scientific knowledge of cardiovascular health and disease.